Aura Biosciences
Valerie Wilkins is a seasoned professional in the field of Clinical Quality Assurance, currently serving as Senior Director of Clinical Quality Assurance at Opthea since June 2024. Prior to this role, Valerie held several key positions including Senior Director of Clinical (GCP) Quality Assurance at Aura Biosciences, Principal Clinical QA and GxP Compliance Consultant at VKW Consulting, and Senior Director of GCP Quality Assurance at ContraFect Corp. Valerie's extensive experience spans various prestigious organizations such as Lantheus Medical Imaging, Sanofi, the Cardiovascular Research Foundation, Amgen, Novartis, and Johnson & Johnson, showcasing a strong background in quality assurance management and compliance. Valerie holds a Bachelor’s degree in Chemistry from West Virginia University.
This person is not in any teams
This person is not in any offices
Aura Biosciences
1 followers
Aura Biosciences is developing a new class of therapies to target and destroy cancer cells selectively, while leaving surrounding tissue unharmed – an approach they call molecular surgery.